Dietary Modification In Inflammatory Bowel Disease Patients

NCT ID: NCT06871267

Last Updated: 2025-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-01

Study Completion Date

2026-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research project aimed to develop a culturally appropriate Asian Inflammatory Bowel Disease Diet for the Malaysian population, based on the Crohn's disease exclusion diet (CDED). The study will be conducted in inflammatory bowel disease patients in University Malaya Medical Centre, which are ulcerative colitis and Crohn's disease patients. The objectives of this study are to assess the impact of diet in clinical outcome and gut microbiota changes in patients with inflammatory bowel disease (IBD). The study duration spans 24 weeks, during which comprehensive follow-ups will be conducted at 0, 6, 12, and 24 weeks, respectively. At each follow-up session, participants will be requested to provide stool and blood samples for meticulous assessment of clinical and biochemical responses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inflammatory bowel disease is a chronic gut inflammation due to immune system dysregulation. Although the exact causes remain unknown, patients' dietary habits were shown to affect the disease activity depending on the food exposure, either proinflammatory or anti-inflammatory food. This randomized-controlled trial (RCT) study aims to improve the modified CDED diet that is acceptable for the Malaysian population at Universiti Malaya Medical Centre. This study comprised of three parts: (Part 1: In-depth interview to measure the acceptance of the diet, Part 2: Implementation of the CDED diet, Part 3: Identification of change in gut microbiome post dietary intervention). The duration of the study is two years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

General Healthy Diet Group

Participants in this group will follow the quarter-quarter-half plate diet based on the Malaysian Healthy Plate guideline.

Group Type ACTIVE_COMPARATOR

General Healthy Diet

Intervention Type BEHAVIORAL

Participants will follow the quarter-quarter-half plate diet as per the Malaysian Healthy Plate guideline.

Crohn's Disease Exclusion Diet (CDED) Group

Participants in this group will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.

Group Type EXPERIMENTAL

Crohn's Disease Exclusion Diet (CDED)

Intervention Type BEHAVIORAL

Participants will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

General Healthy Diet

Participants will follow the quarter-quarter-half plate diet as per the Malaysian Healthy Plate guideline.

Intervention Type BEHAVIORAL

Crohn's Disease Exclusion Diet (CDED)

Participants will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed diagnosis of Crohn's disease according to established clinical, endoscopic, and histological criteria.
* Mild to moderate diseases (150 to 220 points).
* Written informed consent obtained.

Exclusion Criteria

* Presence of stoma.
* Surgery within 6 months prior to randomization.
* Patient on exclusive enteral nutrition (EEN).
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Malaya

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universiti Malaya Medical Centre

Kuala Lumpur, Petaling Jaya, Malaysia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ida Normiha Hilmi, MRCP PhD

Role: CONTACT

0379492868

Nazihah Wafi, BMedSci

Role: CONTACT

0138058802

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ida Hilmi

Role: primary

+0379492965

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024321-13563

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.